Alto Ingredients Inc (ALTO)
Official siteBASIC MATERIALS • SPECIALTY CHEMICALS • NASDAQ
Market Cap: $283.91M
Last updated: Nov 17, 2026 at 4:15 PM ET
Alto Ingredients Inc (ALTO) Stock Chart
Alto Ingredients (ALTO) has a latest price of $3.60 on Nov 17, 2026, 41.1% below its 52-week high of $6.11. Its price rose 76.5% over the past 12 months. The month-end price fell 51.0% over the 10 years through Oct 2026, a compound annual decline of 6.9%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $9.50 in Dec 2016 and its lowest $0.26 in Mar 2020, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart ALTO with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for ALTO.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 14.1%, and over 6 months it fell 23.7%. The month-end price fell 12.3% over the 3 years through Oct 2026, a compound annual decline of 4.3%.
| Period | Change |
|---|---|
| 1 month | +3.2% |
| 3 months | -14.1% |
| 6 months | -23.7% |
| 12 months | +76.5% |
| 12 months, with dividends | +76.5% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -12.3% | -4.3% |
| 5 years | -31.4% | -7.3% |
| 10 years | -51.0% | -6.9% |
Price by Year
Its best calendar year was 2020, when the price rose 735.4%, and its weakest was 2018, when it fell 81.1%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $3.65 | +26.7% |
| 2025 | $2.88 | +84.6% |
| 2024 | $1.56 | -41.4% |
| 2023 | $2.66 | -7.6% |
| 2022 | $2.88 | -40.1% |
| 2021 | $4.81 | -11.4% |
| 2020 | $5.43 | +735.4% |
| 2019 | $0.65 | -24.5% |
| 2018 | $0.86 | -81.1% |
| 2017 | $4.55 | -52.1% |
Trading Range
The price is 3.5% below its 50-day average of $3.73 and 17.1% below its 200-day average of $4.34.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $3.60 | |
| 52-week high | $6.11 | -41.1% |
| 52-week low | $2.00 | +80.0% |
| 50-day average | $3.73 | -3.5% |
| 200-day average | $4.34 | -17.1% |
Price Risk
Over 3 years, its largest fall from a peak was 73.4%.
| Measure | Value |
|---|---|
| 1-year beta | 0.26 |
| Largest fall, 1 year | -42.4% |
| Largest fall, 3 years | -73.4% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About ALTO
What is ALTO's 1-year price change?
Alto Ingredients's price rose 76.5% over the past 12 months. With dividends included, the 12-month total return was 76.5%.
What is ALTO's 5-year price change?
Alto Ingredients's month-end price fell 31.4% over the 5 years through Oct 2026, a compound annual decline of 7.3%. These figures leave out dividends.
What is ALTO's 52-week high and low?
Alto Ingredients's 52-week high is $6.11 and its 52-week low is $2.00. Its latest price of $3.60 on Nov 17, 2026 is 41.1% below the high.
What is ALTO's beta?
Alto Ingredients's 1-year beta against the S&P 500 is 0.26, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 42.4%.
Is the ALTO chart free?
Yes. Advanced Charting for ALTO is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
ALTO pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors